Al-Eryani: Houthis threaten Yemen food ships
Reports reveal that pharmaceutical company Pfizer plans to launch a new COVID-19 vaccine in 2026, targeting a broader population segment approaching age 65. The strategy involves enhancing the vaccine's effectiveness by modifying it to counter new variants of the virus, with the vaccine expected to be released between 2025 and 2026 after receiving regulatory approvals. The company is also preparing global marketing plans to ensure widespread distribution. Additionally, projections indicate that the worldwide COVID-19 vaccine market will reach a value of over $52 billion by 2026, with more than 2,874 million people relying on regular vaccinations.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)